Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03622632
Other study ID # 263425
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date September 30, 2018
Est. completion date September 2020

Study information

Verified date February 2020
Source Hopital du Sacre-Coeur de Montreal
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The goal of this project, is to better understand the fluctuation of the level of uric acid in traumatized patients by making serial measurements during their hospitalization in the intensive care unit. In addition, the determinants (e.g. type of trauma, diseases, interventions) of the blood level of uric acid and its association with the development of organ failure will be sought.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 25
Est. completion date September 2020
Est. primary completion date August 2020
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Direct admission to trauma center

- = 3h after trauma

- ISS = 16

- Received at least 1L of fluid at ER entrance

Exclusion Criteria:

- Isolated head injury

- Isolated spine injury

- Chemotherapy within the last month

- Hematologic disease

- Chronic hemodialysis

- Uricase treatment within the last week

- Expected death within 48h

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Canada Hôpital du Sacré-Cœur de Montréal Montreal Quebec

Sponsors (2)

Lead Sponsor Collaborator
Hopital du Sacre-Coeur de Montreal Fonds de la Recherche en Santé du Québec

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Feasibility of serial plasmatic uric acid sampling after trauma Number of measures collected/number of measures planned 7 days
Secondary Impact of resuscitation on uric acid measures Impact of fluid administration (amount in mL) on the changes of subsequent uric acid blood level 24 to 48 hours
Secondary Clinical predictors of the first blood uric acid (µmol/L) level measured Impact of patient's characteristics and physiological variables on the first measured blood uric acid.
Characteristics will include: age (years), gender, Injury severity score, presence of acute renal impairment.
Physiological variables will include: lower systolic blood pressure, base deficit, lactate level
12 hours
See also
  Status Clinical Trial Phase
Completed NCT03995979 - Inflammation and Protein Restriction N/A
Completed NCT03255187 - Effect of Dietary Supplemental Fish Oil in Alleviating Health Hazards Associated With Air Pollution N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT03577223 - Egg Effects on the Immunomodulatory Properties of HDL N/A
Completed NCT04383561 - Relationship Between LRG and Periodontal Disease N/A
Completed NCT06216015 - Exercise Training and Kidney Transplantation N/A
Completed NCT04856748 - Nomogram to Diagnose Prostatic Inflammation (PIN) in Men With Lower Urinary Tract Symptoms
Completed NCT05529693 - Efficacy of a Probiotic Strain on Level of Markers of Inflammation in an Elderly Population N/A
Recruiting NCT05415397 - Treating Immuno-metabolic Depression With Anti-inflammatory Drugs Phase 3
Recruiting NCT05670301 - Flemish Joint Effort for Biomarker pRofiling in Inflammatory Systemic Diseases N/A
Recruiting NCT05775731 - Markers of Inflammation and of the Pro-thrombotic State in Hospital Shift and Day Workers
Recruiting NCT04543877 - WHNRC (Western Human Nutrition Research Center) Fiber Intervention Study Early Phase 1
Completed NCT03859934 - Metabolic Effects of Melatonin Treatment Phase 1
Completed NCT03429920 - Effect of Fermented Soy Based Product on Cardiometabolic Risk Factors N/A
Completed NCT06065241 - Quantifiably Determine if the Botanical Formulation, LLP-01, Has a Significant Clinical Effect on Proteomic Inflammatory Biomarkers and Epigenetic Changes in Healthy, Older Individuals. N/A
Completed NCT05864352 - The Role of Dietary Titanium Dioxide on the Human Gut Microbiome and Health
Completed NCT03318731 - Efficacy and Safety of Fenugreek Extract on Markers of Muscle Damage and Inflammation in Untrained Males N/A
Not yet recruiting NCT06134076 - Comparing Effects of Fermented and Unfermented Pulses and Gut Microbiota N/A
Not yet recruiting NCT05910489 - Micro and Nanoplastics in Greenhouse Workers: Biomarkers of Exposure and Effect
Not yet recruiting NCT06422494 - The Role of the Adrenergic System in Hypoglycaemia Induced Inflammatory Response in People With Type 1 Diabetes and People Without Type 1 Diabetes-RAID-II N/A